Literature DB >> 27567201

The molecular shape and the field similarities as criteria to interpret SAR studies for fragment-based design of platinum(IV) anticancer agents. Correlation of physicochemical properties with cytotoxicity.

Julia Lorenzo1, Ángel M Montaña2.   

Abstract

Molecular shape similarity and field similarity have been used to interpret, in a qualitative way, the structure-activity relationships in a selected series of platinum(IV) complexes with anticancer activity. MM and QM calculations have been used to estimate the electron density, electrostatic potential maps, partial charges, dipolar moments and other parameters to correlate the stereo-electronic properties with the differential biological activity of complexes. Extended Electron Distribution (XED) field similarity has been also evaluated for the free 1,4-diamino carrier ligands, in a fragment-based drug design approach, comparing Connolly solvent excluded surface, hydrophobicity field surface, Van der Waals field surface, nucleophilicity field surface, electrophilicity field surface and the extended electron-distribution maxima field points. A consistency has been found when comparing the stereo-electronic properties of the studied series of platinum(IV) complexes and/or the free ligands evaluated and their in vitro anticancer activity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticancer agents; Cytotoxicity; Drug likeness; Platinum-based drugs; Shape and field similarity; Stereo-electronic effects; Structure-activity relationship; Structure-related molecular properties; XED field

Mesh:

Substances:

Year:  2016        PMID: 27567201     DOI: 10.1016/j.jmgm.2016.07.010

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  1 in total

1.  Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma.

Authors:  Yang Liu; Hongwu Tian; Liyao Xu; Li Zhou; Jinhu Wang; Benyan Xu; Chunli Liu; Lars I Elding; Tiesheng Shi
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.